• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 92 of 100
Shire Plc's U.K. Offices As Drugmaker Rejects Abbvie Inc.'s $46.5 Billion Offer
HealthShire offers to buy rival drugmaker Baxalta for $30 billion
By ReutersAugust 4, 2015
Brenton Saunders, David Pyott
FinanceFrom Actavis to Allergan: One pharma company’s wild dealmaking journey
By Stacy Jones, Kacy Burdette and Jen WiecznerJuly 30, 2015
Watson computer at IBM in New York City
TechIBM Watson Health now counts CVS Health as a partner
By Jonathan VanianJuly 30, 2015
Marijuana plants for sale are displayed at the medical marijuana farmers market in Los Angeles
TechMedical marijuana firm Potbotics to launch ‘virtual budtenders’
By Dan ReillyJuly 28, 2015
A Teva Pharmaceutical Industries factory in Jerusalem, Israel.
FinanceThe real reasons for the pharma merger boom
By Jen WiecznerJuly 28, 2015
FeaturesThe Fed, GM and a Twitter update–5 things to know today
By Laura Lorenzetti and Geoffrey SmithJuly 28, 2015
Inside Teva Pharmaceuticals Headquarters
EyebrowIsraeli drug firm Teva buys Allergan’s generics business for $40 billion
By Geoffrey SmithJuly 27, 2015
157934085
FinanceTeva in talks to buy Allergan’s generic drug business
By ReutersJuly 26, 2015
FeaturesWorld’s first malaria vaccine, from GlaxoSmithKline, wins approval from EU
By Laura LorenzettiJuly 24, 2015
TechJust like with regular sports, eSports athletes will be tested for drugs
By Chris MorrisJuly 24, 2015
Fight against Daesh in Turkey's Syrian borderline
FeaturesISIS and drug sales — 5 things to know today
By Tom Huddleston Jr. and Geoffrey SmithJuly 24, 2015
Cancer research laboratory
LeadershipDoctors say cancer drug costs are out of control
By Claire GrodenJuly 23, 2015
FeaturesApple aftershock and a new frontier for Alzheimer’s treatments–5 things to know today
By Laura Lorenzetti and Geoffrey SmithJuly 22, 2015
peanuts
TechHow one startup plans to end the EpiPen monopoly
By Corinne IozzioJuly 21, 2015
Apple Worldwide Developers Conference Opens In San Francisco
FeaturesApple, Greek banks, and earnings — 5 things to know this week
By Tom Huddleston Jr.July 19, 2015
1...
  • 90
  • 91
  • 92
  • 93
  • 94
...100
Most Popular
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.